Contribute Try STAT+ Today

For the third time in four months, Lupin Pharmaceuticals, one of India’s biggest suppliers of generic drugs to foreign markets, has been admonished by the Food and Drug Administration for a series of troubling quality-control issues at a manufacturing facility.

In a recent inspection report, the regulator cited the company for failing to thoroughly review unexplained deficiencies in batches of medicines and not taking “scientifically sound” steps to evaluate samples; delays in assessing health hazards; insufficiently investigating customer complaints, including an instance involving mold on medicines shipped to the U.S.; and a lack of oversight and training.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Hi, I had a heart attack on Labor Day 9/2/2019 and feel it is the fault of this Lupin Lovistatin I began taking on 5/26/2019, after 4 years taking a different brand Teva with no problems. My yearly checkup Jan 2019 with my Cardiologist had me a 120/80 BP with over 95% hear function after 4 years since my first heart attack May of 2015. The Giant Eagle Pharmacy told me Lupin was replacing the 20mg Teva brand when I got my refill 5/26/2019. After about a month I noticed discomfort in my chest, questioned the change of brands, found out there was a recall of 40mg Lovi’s from Lupin in Feb 2019 which the pharmacy said they were aware of but the 20mg weren’t effected so I continued taking & the discomfort continued so i requested my next refill on 8/26/2019 be Teva 10mg, 2 a day which i got but the damage was done & by 9/2 I was code purple in the ER, 100% blockage of the Widowmaker & 95% of the main right artery. I know its the Lupin. Now I’m screwed, on a longer road to recovery & may never have as good a functioning heart again. If you know of anything I could do along with more info on Lupin please let me know. I live in Lorain Ohio & Thank God for the staff at Mercy Hospital for saving my life but any help in direction & support from you would be appreciated. Thanks John Jannuzzi (440)949-0352 Please send me this email back so I have a record of it also….cool

Comments are closed.

Your daily dose of news in health and medicine

Privacy Policy